
Aytu BioScience AYTU
€ 2.27
-0.19%
Quartalsbericht 2025-Q4
hinzugefügt 03.02.2026
Aytu BioScience P/CF 2011-2026 | AYTU
P/CF Jährlich Aytu BioScience
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.14 | -11.4 | -2.04 | -0.00969 | -0.645 | -2.18 | -0.898 | -0.233 | -0.394 | -1.13 | -0.817 | -0.191 | -24.8 | -86.6 | -20.2 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -0.00969 | -86.6 | -10.6 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.654 | - | 2.43 % | $ 254 M | ||
|
Graybug Vision
GRAY
|
-0.0767 | - | -11.23 % | $ 9.65 M | ||
|
AbCellera Biologics
ABCL
|
-7.33 | $ 3.64 | -1.89 % | $ 1.09 B | ||
|
ADMA Biologics
ADMA
|
75 | $ 16.45 | 0.43 % | $ 3.92 B | ||
|
I-Mab
IMAB
|
-0.266 | - | - | $ 866 M | ||
|
ANI Pharmaceuticals
ANIP
|
18.7 | $ 76.75 | 0.85 % | $ 1.48 B | ||
|
Apellis Pharmaceuticals
APLS
|
61.2 | $ 19.93 | -1.14 % | $ 2.51 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
11.6 | - | - | $ 40.3 B | ||
|
Acer Therapeutics
ACER
|
-0.401 | - | 2.71 % | $ 14 M | ||
|
Biophytis SA
BPTS
|
-23.1 | - | -13.47 % | $ 169 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.0776 | - | -11.43 % | $ 502 K | ||
|
Aptorum Group Limited
APM
|
-3.44 | $ 0.83 | 4.23 % | $ 4.53 M | ||
|
Athersys
ATHX
|
-5.78 | - | 3.77 % | $ 22.4 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.88 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | - | -18.52 % | $ 27.3 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-1.71 | - | - | $ 521 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | - | -4.8 % | $ 255 M | ||
|
Burford Capital Limited
BUR
|
11.6 | $ 8.4 | -1.81 % | $ 1.39 B | ||
|
Axsome Therapeutics
AXSM
|
-92.9 | $ 163.82 | -0.14 % | $ 8.15 B | ||
|
Adverum Biotechnologies
ADVM
|
-0.826 | - | - | $ 86.2 M | ||
|
BridgeBio Pharma
BBIO
|
-29.4 | $ 66.98 | 3.8 % | $ 12.8 B | ||
|
CymaBay Therapeutics
CBAY
|
-47.3 | - | - | $ 3.45 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - | ||
|
Avid Bioservices
CDMO
|
38.7 | - | - | $ 789 M | ||
|
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | ||
|
Checkpoint Therapeutics
CKPT
|
-5.15 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-0.185 | - | -16.75 % | $ 25.8 M | ||
|
Alpine Immune Sciences
ALPN
|
-6.14 | - | - | $ 2.17 B | ||
|
BioLineRx Ltd.
BLRX
|
-57.4 | $ 2.88 | 2.51 % | $ 908 M | ||
|
Clovis Oncology
CLVS
|
-1.18 | - | -7.23 % | $ 13 M | ||
|
Acorda Therapeutics
ACOR
|
-1.2 | - | -24.86 % | $ 820 K | ||
|
BioMarin Pharmaceutical
BMRN
|
14.1 | $ 60.75 | 3.79 % | $ 11.7 B | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.982 | - | - | $ 231 M | ||
|
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | ||
|
CTI BioPharma Corp.
CTIC
|
-6.78 | - | - | $ 1.2 B | ||
|
CohBar
CWBR
|
-0.508 | - | -15.44 % | $ 2.2 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-0.698 | - | -5.98 % | $ 34.1 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
-13.7 | - | -4.36 % | $ 27 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-8.18 | - | - | $ 2.18 B | ||
|
CureVac N.V.
CVAC
|
-4.82 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | - | 5.93 % | $ 314 M | ||
|
Cabaletta Bio
CABA
|
-0.383 | $ 3.41 | 4.77 % | $ 3.98 M | ||
|
Capricor Therapeutics
CAPR
|
-6.07 | $ 25.71 | -0.5 % | $ 688 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | ||
|
Codexis
CDXS
|
-5.9 | $ 1.1 | 12.24 % | $ 80.7 M | ||
|
Certara
CERT
|
11.2 | $ 7.33 | 1.24 % | $ 1.18 B | ||
|
Entasis Therapeutics Holdings
ETTX
|
-1.71 | - | - | $ 105 M | ||
|
Evofem Biosciences
EVFM
|
-0.431 | - | 7.55 % | $ 38.1 M |